Corporate symposia schedule

All symposia will be held at the Marriott Wardman Park Hotel.

Sunday, June 10

AD Biomarkers for Diagnosis and Drug Development: Recent Progress

6:30 p.m.
Location: Marriott Ballroom Salons 2 & 3

Sponsored by Innogenetics

Biomarkers are today considered to be an essential means to improve the diagnosis of Alzheimer’s disease and accelerate drug development. This Symposium discusses recent clinical results and new biomarker tests that could provide clinicians and research scientists with exciting new opportunities to make early diagnosis and disease-modifying treatments a reality.

Monday, June 11

Testing the Therapeutic Value of the Amyloid Hypothesis: Rationale and Methods for Testing Amyloid-Beta Lowering Drugs

6:30 p.m.
Location: Maryland Room

Sponsored by Lilly

This symposium will examine the Amyloid hypothesis in the treatment of AD. Potential therapeutic agents such as secretase inhibitors, processing modulators, antibodies and aggregation inhibitors will be discussed. In addition biomarker (animal models and also human data) and clinical data for selected agents in clinical development will be discussed.